Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia

30Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized by cranial dysplasia, clavicle hypoplasia and dental abnormalities. This disease is mainly caused by heterozygous mutations in RUNX2, a gene that encodes an osteoblast-specific transcription factor. In the present study, mutational analyses of RUNX2 gene were performed on four unrelated Chinese patients with CCD. Four different RUNX2 mutations were detected in these patients, including one nonsense mutation (c.199C>T p.Q67X) and three missense mutations (c.338T>G p.L113R, c.557G>C p.R186T and c.673C>T p. R225W). Among them, two mutations (c.199C>T p.Q67X and c.557G>C p.R186T) were novel and the other two had been reported in previous literatures. Except for Q67X mutation located in the Q/A domain, other three mutations were clustered within the highly conserved Runt domain. Green fluorescent protein (GFP) and RUNX2 fusion protein analyses in vitro showed that nuclear accumulation of RUNX2 protein was disturbed by Q67X mutation, while the other two mutations (c.338T>G p.L113R and c.557G>C p.R186T) had no effects on the subcellular distribution of RUNX2. Luciferase reporter assay demonstrated that all the three novel RUNX2 mutations significantly reduced the transactivation activity of RUNX2 on osteocalcin promoter. Our findings enrich the evidence of molecular genetics that the mutations of RUNX2 gene are responsible for CCD.

References Powered by Scopus

Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation

3790Citations
N/AReaders
Get full text

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

2515Citations
N/AReaders
Get full text

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia

1327Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Syringic acid, a phenolic acid, promotes osteoblast differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal stem cells

59Citations
N/AReaders
Get full text

RUNX2 Regulates Osteoblast Differentiation via the BMP4 Signaling Pathway

31Citations
N/AReaders
Get full text

Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion

27Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, X., Liu, Y., Wang, X., Sun, X., Zhang, C., & Zheng, S. (2017). Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia. PLoS ONE, 12(7). https://doi.org/10.1371/journal.pone.0181653

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Researcher 2

25%

Lecturer / Post doc 1

13%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 3

38%

Medicine and Dentistry 3

38%

Pharmacology, Toxicology and Pharmaceut... 1

13%

Arts and Humanities 1

13%

Save time finding and organizing research with Mendeley

Sign up for free